Ipilimumab/nivolumabImmune related myositis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1827卷 / 1期

关键词：

D O I：

10.1007/s40278-020-84940-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：185 / 185

相关论文

共 50 条

[1] Ipilimumab/nivolumabImmune-related myositis: case report
Reactions Weekly, 2023, 1944 (1) : 321 - 321
[2] Ipilimumab/nivolumabImmune related toxicities: case report
Reactions Weekly, 2022, 1901 (1) : 280 - 280
[3] Ipilimumab/nivolumabImmune-related thyroiditis: case report
Reactions Weekly, 2022, 1907 (1) : 268 - 268
[4] Ipilimumab/nivolumabImmune-related hepatitis: case report
Reactions Weekly, 2020, 1792 (1) : 134 - 134
[5] Ipilimumab/nivolumabImmune-related hypoadrenocorticism: case report
Reactions Weekly, 2024, 2034 (1) : 185 - 185
[6] Ipilimumab/nivolumabImmune-related myocarditis : case report
Reactions Weekly, 2023, 1957 (1) : 312 - 312
[7] Ipilimumab/nivolumabImmune-related colitis: case report
Reactions Weekly, 2023, 1961 (1) : 236 - 236
[8] Ipilimumab/nivolumabImmune-related bronchiolitis: case report
Reactions Weekly, 2024, 2037 (1) : 220 - 220
[9] Ipilimumab/nivolumabImmune related adverse events: case report
Reactions Weekly, 2019, 1749 (1) : 226 - 226
[10] Ipilimumab/NivolumabImmune-related myocarditis: case report
Reactions Weekly, 2024, 2032 (1) : 221 - 221

← 1 2 3 4 5 →